Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer
1 other identifier
observational
100
1 country
1
Brief Summary
This study will compare two ways of having people respond to a questionnaire about health and emotional well-being: on a computer and with paper and pencil. We will see how long it takes using both methods. We will also ask you how you feel about using a computer to answer the questions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2004
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2004
CompletedFirst Submitted
Initial submission to the registry
December 20, 2007
CompletedFirst Posted
Study publicly available on registry
December 24, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2008
CompletedJuly 28, 2008
July 1, 2008
3.9 years
December 20, 2007
July 24, 2008
Conditions
Keywords
Eligibility Criteria
adult survivors of childhood cancer
You may qualify if:
- Currently at least 18 years of age and not older than 49 years of age
- Diagnosed with first malignancy before the age of 22
- Completed all cancer treatment at least three years prior
- Able to complete the survey instruments in English
- Scheduled for a routine off-treatment follow-up oncology appointment
- Currently disease-free and not receiving any cancer treatment
You may not qualify if:
- History of a central nervous system tumor
- A sensory or cognitive impairment that would interfere with completion of the survey
- Currently undergoing treatment by a psychiatrist or psychologist (ie., currently receiving psychotherapy and/or psychotropic medications, as per self-report)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
Related Links
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Ford, PhD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 20, 2007
First Posted
December 24, 2007
Study Start
August 1, 2004
Primary Completion
July 1, 2008
Study Completion
July 1, 2008
Last Updated
July 28, 2008
Record last verified: 2008-07